← Back to Patent Explorer
US4859677A Expired / Lapsed US ⏱️ 0.0 years remaining

Nucleoside analogues having antiviral activity

Assignee: University of Kansas
•
Filing: 1987-04-17
•
Granted: 1989-08-22
•
Expires: 2007-04-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula (I) ##STR1## wherein X is ═N-- or ═CH-- and physiologically acceptable salts and solvents thereof which have antiviral activity, a process for the preparation of the compounds and intermediates thereof, pharmaceutical compositions containing the compounds and a method for inhibiting the propagation of virus using the compounds.

Inventors

  • 👤 Ronald T. Borchardt
  • 👤 David R. Borcherding

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 00:32
CPC Classifications
C; C07; C07D; C07D473/00; C07D471/00; C07D471/02; C07D471/04

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 20 words
A compound of the formula (I) wherein X is ═N-- or ═CH-- or a physiologically acceptable salt or solvate thereof.
Claim 2
Dependent Claim 20 words
A compound of the formula (I) wherein X is ═N-- or ═CH-- or a physiologically acceptable salt or solvate thereof.
Claim 3
Dependent Claim 10 words
The compound of claim I which has the formula ##STR32##
Claim 4
Dependent Claim 9 words
The compound of claim 2, wherein X is ═N--.
Claim 5
Dependent Claim 9 words
The compound of claim 2, wherein X is ═CH--.
Claim 6
Dependent Claim 19 words
An antiviral composition comprising an effective antiviral amount of the compound of claim 1, and a pharmaceutically effective carrier.
Claim 7
Dependent Claim 19 words
An antiviral composition comprising an effective antiviral amount of the compound of claim 2, and a pharmaceutically effective carrier.
Claim 8
Dependent Claim 9 words
The composition of claim 6, wherein X is ═N--.
Claim 9
Dependent Claim 9 words
The composition of claim 6, wherein X is ═CH--.
Claim 10
Dependent Claim 15 words
The composition of claim 7 which contains an effective anti poxvirus amount of said compound.
Claim 11
Dependent Claim 15 words
The composition of claim 8 which contains an effective anti poxvirus amount of said compound.
Claim 12
Dependent Claim 15 words
The composition of claim 7 which contains an effective anti reovirus amount of said compound.
Claim 13
Dependent Claim 15 words
The composition of claim 8 which contains an effective anti reovirus amount of said compound.
Claim 14
Dependent Claim 20 words
The composition of claim 7 which contains an effective anti measles, parainfluenza or vesicular stomatitis virus amount of said compound.
Claim 15
Dependent Claim 20 words
The composition of claim 8 which contains an effective anti measles, parainfluenza or vesicular stomatitis virus amount of said compound.
Claim 16
Dependent Claim 34 words
A method for treating viral infections which comprises administering an effective antiviral amount of the composition of claim 7 to a subject infected with poxvirus, reovirus, measles virus, parainfluenza virus or vesicular stomatitis virus.
Claim 17
Dependent Claim 20 words
A pharamaceutical composition comprising 0.1 to 99% by weight of the compound of claim 1 and a pharmaceutically effective carrier.

References Cited (Backward Citations)

US3825541A Cited
US4199574A Cited
US3917837A Cited
US4423218A Cited
US4321376A Cited
US4613666A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-08-21 1993-02-20 1993-08-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-08-21 1997-02-20 1997-08-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-08-21 2001-02-20 2001-08-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag